Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Adimmune Corporation (4142.TW), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
160.00
P/B ratioShare price divided by book value per share.
1.75
P/S ratioMarket value divided by annual revenue.
5.91
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-110.56
EV / RevenueEnterprise value against annual revenue.
6.85
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
0.63%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
23.10%
Operating marginRevenue left after operating costs.
-258.72%
Net marginRevenue left after every cost, including tax and interest.
-10.48%
Return on equityProfit as a percentage of shareholders’ equity.
-4.40%
Return on assetsProfit as a percentage of total assets.
-1.99%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
4.47
Quick ratioThe same, excluding inventory.
2.77
Debt to equityTotal borrowings against shareholders’ equity.
0.64
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-0.34
Book value per shareShareholders’ equity divided by shares outstanding.
$10.97
Shares outstandingShares currently issued.
421,508,000
Market capitalisationShare price times shares outstanding.
$8.09B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
564
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.